一线用药EGFR—TKIs与化疗治疗非选择型NSCLC效果的Meta分析(4)
[4] Crino L，Cappuzzo F，Zatloukal P，et al. Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE)：a randomized，phase II study [J]. J Clin Oncol，2008，26(26)：4253-4260.[5] Chen YM，Tsai CM，Fan WC，et al. Phase Ⅱ randomized trial of erlotinib or vinorelbine in chemonaive，advanced，non-small cell lung cancer patients aged 70 years or older [J]. J Thorac Oncol ......
您现在查看是摘要页，全文长 3768 字符。